Israel's Inspira explores use of ART100 device to provide neonates with vital respiratory support

Israel-based Inspira Technologies has announced the commencement of a programme to explore the applicable use of the INSPIRA ART100 device for an artificial womb for neonates in need of vital respiratory support.

Inspira aims to explore how this potential additional application of the INSPIRA ART100 device to provide neonates with vital respiratory support could replace the currently used mechanical ventilators. The potential application of this device will primarily target prematurely born neonates with underdeveloped respiratory systems and neonates with life-threatening disorders such as meconium aspiration syndrome, and congenital diaphragmatic hernia.

The high pressure and complications associated with mechanical ventilation can cause harsh and long-term negative effects on neonates who require respiratory life support during the early and critical stages of their neonatal development.

Dagi Ben-Noon, CEO of Inspira Technologies, said, "This initiative marks another step in the journey towards providing safer alternatives to mechanical ventilation. Together, we are targeting to reshape the landscape of acute neonatal care."